Skip to content
10-K

Annual Report

ACCUSTEM SCIENCES, INC. ACUT

0001641172-25-002594

← back to feed
Filed
Apr 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 31, 2025 12.1M sh
Shares Diluted FY 2024 · Dec 31, 2023 11.35M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$1.62M
Current Liabilities FY 2024 · Dec 31, 2023 $2.25M
Total Liabilities FY 2024 · Dec 31, 2023 $2.25M
Current Assets FY 2024 · Dec 31, 2023 $129.85K
Total Assets FY 2024 · Dec 31, 2023 $133.9K
Eps Diluted FY 2024 · Dec 31, 2023 −$0.18
Eps Basic FY 2024 · Dec 31, 2023 −$0.18
Sga Expense FY 2024 · Dec 31, 2023 $1.91M
Rd Expense FY 2024 · Dec 31, 2023 $139.66K
Net Income FY 2024 · Dec 31, 2023 −$2.05M
Operating Income FY 2024 · Dec 31, 2023 −$2.05M
Stockholders Equity FY 2024 · Dec 31, 2022 −$139.55K